Furthermore, ANXA2, C8orf33 and IGF2BP3 were demonstrated to be associated with the survival time of HCC patients, which suggested that they could be considered as prognosis factors for HCC. The gene discussed is ANXA2; the disease is hepatocellular carcinoma.